E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.

[1]  S. Groshen,et al.  Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Bernard Rachet,et al.  Cancer survival in five continents: a worldwide population-based study (CONCORD). , 2008, The Lancet. Oncology.

[3]  H. Comber,et al.  Inequity in colorectal cancer treatment and outcomes: a population-based study , 2008, British Journal of Cancer.

[4]  K. Konstantopoulos,et al.  Carcinoembryonic Antigen and CD44 Variant Isoforms Cooperate to Mediate Colon Carcinoma Cell Adhesion to E- and L-selectin in Shear Flow* , 2008, Journal of Biological Chemistry.

[5]  A. Russo,et al.  Role of S128R polymorphism of E‐selectin in colon metastasis formation , 2007, International journal of cancer.

[6]  D. Sargent,et al.  Current Issues in Adjuvant Treatment of Stage II Colon Cancer , 2006, Annals of Surgical Oncology.

[7]  Markus Abt,et al.  Capecitabine as adjuvant treatment for stage III colon cancer. , 2005, The New England journal of medicine.

[8]  J. Manson,et al.  E-selectin genotypes and risk of type 2 diabetes in women. , 2005, Obesity research.

[9]  Rainer Fietkau,et al.  Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.

[10]  T. Hickish,et al.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.

[11]  S. Cha,et al.  Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Kimura,et al.  E-Selectin Polymorphism Associated With Myocardial Infarction Causes Enhanced Leukocyte-Endothelial Interactions Under Flow Conditions , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[13]  D. Haskard,et al.  Enhanced Recruitment of Th2 and CLA-Negative Lymphocytes by the S128R Polymorphism of E-Selectin1 , 2002, The Journal of Immunology.

[14]  S. Ortlepp,et al.  The S128R polymorphism of E‐selectin mediates neuraminidase‐resistant tethering of myeloid cells under shear flow , 2002, European journal of immunology.

[15]  T. Conroy,et al.  Carcinoma of the colon , 2001, British Journal of Cancer.

[16]  D. Nance,et al.  Interactions between cancer cells and the endothelium in metastasis , 2000, The Journal of pathology.

[17]  G. Baumann,et al.  Functional Characterization of Atherosclerosis-Associated Ser128Arg and Leu554Phe E-Selectin Mutations , 1999, Biological chemistry.

[18]  F. Révillion,et al.  Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  K. Livak,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay. , 1999, Genetic analysis : biomolecular engineering.

[20]  L. Hornez,et al.  Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. , 1998, Cancer research.

[21]  F. Révillion,et al.  The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  D. Scott,et al.  Single Amino Acid Residues in the E- and P-selectin Epidermal Growth Factor Domains Can Determine Carbohydrate Binding Specificity* , 1996, The Journal of Biological Chemistry.

[23]  G. Baumann,et al.  E-selectin polymorphism and atherosclerosis: an association study. , 1994, Human molecular genetics.

[24]  A. Speer,et al.  Polymorphism in the human E-selectin gene detected by PCR-SSCP , 1994, Human Genetics.

[25]  K. Rohde,et al.  DMA polymorphisms in adhesion molecule genes — a new risk factor for early atherosclerosis , 2004, Human Genetics.

[26]  Thomas Weber,et al.  Genetic Polymorphisms in Cytokine and Adhesion Molecule Genes in Coronary Artery Disease , 2003, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[27]  T Foitzi,et al.  Allelic discrimination using fluorogenic probes and the 5' nuclease assay , 1999 .

[28]  Y. Chung,et al.  Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line. , 1997, British Journal of Cancer.